Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03165175 · ClinicalTrials.gov registry record · NA
Mobile Application for Prescription Drug-Abuse Education (MAPDE)
A NA study, sponsored by Naval Health Research Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03165175 is a NA study that has completed, run by Naval Health Research Center. The registered enrollment target is 80 participants.
The verdict
NCT03165175, a NA study, has completed, sponsored by Naval Health Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aims of this pilot study are: (1) to assess the feasibility and acceptability of a mobile application to educate military members about the risks of prescription drug misuse; (2) to determine if there is evidence that the mobile application plus treatment as usual reduces the risk of prescription drug misuse and shows differences in related measures compared to treatment as usual among military medical clinic patients currently taking prescription medication; and (3) if evidence of reduced risk is found, to estimate effect sizes for a future effectiveness trial. The pilot study will use a randomized controlled design with two groups. The control group will be provided with treatment as usual (TAU), and the experimental group will be provided with the prescription drug-abuse educational smartphone application in addition to treatment as usual (app + TAU). Self-reported measures of risk of misuse and related attitudes and knowledge will be administered to all participants at baseline, 1 month, and 3 months. The mobile app is a brief intervention designed to help military members to assess their risk for medication misuse and provide individualized feedback on risk level with recommendations for reducing risk. The app also contains other features, including sections in which to store information on current medications and look up drug interactions and provides resources for help.
Interventions
- BEHAVIORAL prescription drug-abuse education smartphone application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2018-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03165175
The ClinicalTrials.gov registry entry for NCT03165175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Naval Health Research Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which prescription drug-abuse education smartphone application is the first listed.
NCT03165175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03165175 about?
NCT03165175 is a clinical study titled "Mobile Application for Prescription Drug-Abuse Education (MAPDE)". The aims of this pilot study are: (1) to assess the feasibility and acceptability of a mobile application to educate military members about the risks of prescription drug misuse; (2) to determine if there is evidence that the mobile application plus treatment as usual reduces the risk of prescriptio...
What is the current status of trial NCT03165175?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-05-22. Estimated completion is 2018-10-17.
What interventions are being tested in trial NCT03165175?
The interventions under investigation include: prescription drug-abuse education smartphone application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03165175?
This trial is sponsored by Naval Health Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.